
For the last decade, Ronald Ackermann, MD, MPH, has worked on implementing a method to halt diabetes that is both effective for patients and affordable for insurers. He and colleagues have focused on adapting an intervention called the Diabetes Prevention Program.

The latest government guidelines for diabetes screening missed 55 percent of high-risk individuals with prediabetes or diabetes, a new Northwestern Medicine study found.

Northwestern Medicine physicians participated in a clinical trial to investigate the safety and efficacy of a drug for weight management in overweight or obese adults with type 2 diabetes.